BDB001-101: Clinical Study of BDB001 as a Mono-therapy or in Combination With Pembrolizumab
Clinical trial NCT03486301 · COMPLETED
Trial details
- NCT number
- NCT03486301
- Sponsor
- Eikon Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-15
- Primary completion
- 2024-03-31
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.